In Bangladesh,
obesity and type 2 diabetes are rising together. Controlling blood sugar alone should not be the only goal; meaningful weight reduction matters too.
Everest Pharma Introduces
𝗧𝗜𝗥𝗭𝗜𝗗𝗘
(Tirzepatide INN) as Pre-filled Inj
Feel Light, Feel Bright
1st time
in Bangladesh
Everest Pharma Introduces
A new class for relentlees acid relief
VONOSIL 10 & 20 mg Tablet
(A brand of Vonoprazan INN)
400 times more efficacious than PPIs
1st time in Bangladesh
Everest Pharma
Introduces
The Game Changer in Chronic Cough Treatment
Gefan Tablet
(A brand of Gefapixant 45 mg)
1st-in-class NON-Narcotic
Purinergic Receptor, P2X3 antagonist
To
Raising the Bar in
CKD Anemia Treatment
Everest Pharma Introduces
First Global version Daprodustat in Bangladesh
DAPROSTAT TABLET
(a brand of Daprodustat)
USFDA approved the one and only HIF-PH inhibitor for CKD anemia
বিশ্ব ক্যান্সার দিবস
শনিবার, ৪ ফেব্রুয়ারী ২০২৩।
পৃষ্ঠা ১১ | দৈনিক প্রথম আলো
“বাংলাদেশের ক্যান্সার চিকিৎসা : বর্তমান প্রেক্ষাপট এবং
ভবিষ্যৎ সম্ভাবনা “
Prothom Alo | Everest Pharmaceuticals Ltd.
With the Renowned
Nephrologist
Prof. Dr. Ashok L. Kirpalani, MD, MCPS, MNAMS
Emeritus Professor of Nephrology,
Department of Nephrology
Bombay Hospital Institute of Medical Science
International
CME on
“Update on the Management
of Diabetic Kidney Disease”
Monday , 26th September’22
Time : 12:30 PM, Venue : Hotel Intercontinental
Organised by : Bangladesh Endocrine Society
Powered by :
Fineron | Everest Pharmaceuticals Ltd.